An update from CStone Pharmaceuticals ( (HK:2616) ) is now available.
CStone Pharmaceuticals has announced a placement of 80 million new shares at a price of HK$2.933 per share, representing a discount to recent trading prices. This move is expected to raise gross proceeds of HK$234.64 million, which will contribute to the company’s financial resources. The placement is contingent upon approval from the Stock Exchange’s listing committee and other conditions, and it will increase the company’s issued share capital by approximately 5.86%. Shareholders and potential investors are advised to exercise caution as the completion of the placement is not guaranteed.
More about CStone Pharmaceuticals
CStone Pharmaceuticals is a biopharmaceutical company incorporated in the Cayman Islands, focusing on the development and commercialization of innovative immuno-oncology therapies and precision medicines. The company is listed on the Stock Exchange of Hong Kong and is involved in the pharmaceutical industry.
YTD Price Performance: 43.91%
Average Trading Volume: 4,562,731
Technical Sentiment Signal: Sell
Current Market Cap: HK$4.18B
See more insights into 2616 stock on TipRanks’ Stock Analysis page.